CYP1A2 genetic polymorphisms are associated with treatment response to the antidepressant paroxetine. (Q42788954)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21121774%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

CYP1A2 genetic polymorphisms are associated with treatment response to the antidepressant paroxetine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21121774%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21121774%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Chi-Shin Wu

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21121774%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Keh-Ming Lin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21121774%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

I-Ju Tsai

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21121774%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Mei-Chun Hsiao

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21121774%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Chin-Fu Hsiao

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21121774%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Chia-Yih Liu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21121774%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Winston W Shen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21121774%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Hwa-Sheng Tang

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21121774%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Chun-Kai Fang

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21121774%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Shao-Chun Lu

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21121774%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Hsiang-Wei Kuo

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21121774%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Shu Chih Liu

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21121774%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Hsiu-Wen Chan

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21121774%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Ya-Ting Hsu

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21121774%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Jia-Ni Tian

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21121774%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Yu-Li Liu

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21121774%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

1 November 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21121774%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21121774%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21121774%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21121774%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

1535-1543

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21121774%20AND%20SRC:MED&resulttype=core&format=json

A multifactorial developmental model for the etiology of major depression in a population-based sample.

17 January 2020

cites work

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.128

Patients with depressive disorder, their co-morbidity, visiting rate and disability in relation to self-evaluation of physical and mental health: a cross-sectional study in family practice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.128

The prevalence and incidence of treated major depressive disorder among National Health Insurance enrollees in Taiwan, 1996 to 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.128

Meta-analysis of major depressive disorder relapse and recurrence with second-generation antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.128

Pharmacogenetics of antidepressive treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.128

The pharmacogenetics of major depression: past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.128

Paroxetine: current status in psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.128

Identification of cytochrome P450 isoforms involved in the metabolism of paroxetine and estimation of their importance for human paroxetine metabolism using a population-based simulator

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.128

Pharmacogenetics, drug-metabolizing enzymes, and clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.128

Simultaneous determination of citalopram, fluoxetine, paroxetine and their metabolites in plasma and whole blood by high-performance liquid chromatography with ultraviolet and fluorescence detection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.128

Interaction of serotonin reuptake inhibitors with tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.128

A case with occurring adverse effects when cross-over titration from fluvoxamine to paroxetine associated with increasing the plasma fluvoxamine level in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.128

Antidepressant drug-drug interaction profile update

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.128

Pharmacogenetics and olanzapine treatment: CYP1A2*1F and serotonergic polymorphisms influence therapeutic outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.128

Development of a Rating Scale for Primary Depressive Illness

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.128

Polymorphisms in the drug transporter gene ABCB1 predict antidepressant treatment response in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.128

A rating scale for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.128

Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.128

Training and quality assurance with the Structured Clinical Interview for DSM-IV (SCID-I/P).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.128

Standardized rater training for the Hamilton Depression Rating Scale (HAMD-17) in psychiatric novices

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.128

Weighted kappa: nominal scale agreement with provision for scaled disagreement or partial credit

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.128

Pharmacogenetics of anxiolytic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.128

Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.128

FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.128

Haploview: analysis and visualization of LD and haplotype maps

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.128

The structure of haplotype blocks in the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.128

Is therapeutic drug monitoring a case for optimizing clinical outcome and avoiding interactions of the selective serotonin reuptake inhibitors?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.128

Functional significance of a C-->A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.128

A functional polymorphism of the cytochrome P450 1A2 (CYP1A2) gene: association with tardive dyskinesia in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.128

Genetic polymorphisms of cytochrome P450 enzymes influence metabolism of the antidepressant escitalopram and treatment response.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.128

Lifetime and twelve-month prevalence rates of major depressive episodes and dysthymia among Chinese Americans in Los Angeles

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.128

A Coefficient of Agreement for Nominal Scales

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FPGS.10.128